Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Debt (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Total Debt readings, the most recent being $264092.0 for Q1 2026.

  • On a quarterly basis, Total Debt fell 18.17% to $264092.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $264092.0, a 18.17% decrease, with the full-year FY2025 number at $264092.0, up 5.91% from a year prior.
  • Total Debt reached $264092.0 in Q1 2026 per CBIH's latest filing, roughly flat from $264092.0 in the prior quarter.
  • The five-year high for Total Debt was $322729.0 in Q1 2025, with the low at $249361.0 in Q2 2024.
  • A 4-year average of $265157.9 and a median of $264092.0 in 2023 define the central range for Total Debt.
  • Year-over-year, Total Debt grew 25.79% in 2025 and then dropped 18.17% in 2026.
  • Year by year, Total Debt stood at $261579.0 in 2023, then grew by 0.96% to $264092.0 in 2024, then changed by 0.0% to $264092.0 in 2025, then changed by 0.0% to $264092.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Total Debt are $264092.0 (Q1 2026), $264092.0 (Q4 2025), and $249500.0 (Q3 2025).